Founding Sponsors Finalize Complete Exit, Selling Remaining $486M Stake
Summary
Sotera Health's founding sponsors, Warburg Pincus and GTCR, have finalized the sale of their remaining 31.8 million shares for $486.17 million, completing their exit and ending their special governance rights.
Key Events
-
Finalizes Sponsor Exit
Warburg Pincus and GTCR affiliates sold their remaining 31,838,253 shares of common stock at $15.27 per share, totaling $486.17 million. This finalizes the offering initiated on May 11, 2026.
-
Complete Divestment
Following this transaction, the founding sponsors will no longer hold any shares of Sotera Health common stock, marking a complete divestment of their stake.
-
Termination of Governance Rights
The Sponsors' special corporate governance rights, including the ability to designate directors, will terminate upon the completion of this offering.
-
No Proceeds to Company
Sotera Health will not receive any proceeds from this secondary offering, as all shares are being sold by existing stockholders.
Analysis
This filing finalizes the terms of the secondary offering by Warburg Pincus and GTCR, marking their complete exit from Sotera Health. The sale of 31.8 million shares, valued at $486.17 million, represents a significant shift in the company's ownership structure. The departure of these founding sponsors also terminates their special corporate governance rights, which could impact future board composition and strategic direction. This follows a pattern of significant insider distribution over the past 90 days.
At the time of this filing, SHC was trading at $15.61 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.5B. The 52-week trading range was $10.80 to $19.85. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.